CoverageForm 410-K10-Q8-K13D13G13F

TOI Oncology Institute, Inc. - 8-K

Filed May 22, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001079973-26-000721
1.059.01

Item 1.05 - (unknown item)

688 words

Item 1.05 Material Cybersecurity Incidents.

The Oncology Institute, Inc. (the “Company”) is providing
this disclosure, as a follow-up to its voluntary disclosure in Item 7.01 of a Current Report on Form 8-K filed on November 6, 2025, regarding
a cybersecurity incident affecting a software service provider (“Vendor”) utilized by the Company. At the time of the prior
voluntary disclosure, the Vendor had indicated that investigation was still ongoing and it could not yet confirm any evidence that any
patient personal information was compromised as a result of this incident. However, on May 20, 2026, Kroll, who is the third-party administrator
for the Vendor, notified the Company that the Vendor had detected unauthorized access by a third party to certain information systems
of the Company, including systems affecting data of patients. The Company believes that the cybersecurity incident has affected various
other healthcare service providers, and the Vendor has set up a patient portal through which it intends to provide information and responses
to inquiries.

Because of the Company’s technology security and continuity plan,
the Company worked swiftly in response, and its operations have continued in all material respects since the detection of the incident.
The Company remains committed to protecting the healthcare and other personal information of its patients and will work with the Vendor
to offer credit monitoring and protection to all impacted patients.

The Company is reserving all rights with respect to potential claims
against relevant third parties or service providers. Although the Company’s investigation and assessment remain ongoing, as of the
date of this filing, the Company believes that the incident has not had a material impact on the Company’s operations, financial
systems, or its quality of care to its patients, and the Company is currently evaluating any other material impact, if any, including
on its financial condition or results of operations.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains statements about future events
and expectations which are “forward-looking statements” within the meaning of Sections 27A of the Securities Act of 1933,
as amended, and 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by forward-looking
words such as “may,” “might,” “could,” “would,” “should,” “will,”
“anticipate,” “believe,” “plan,” “estimate,” “project,” “expect,”
“intend,” “seek,” “are encouraged,” and other similar expressions. Any statement contained in this
Current Report on Form 8-K that is not a statement of historical fact may be deemed to be a forward-looking statement. All forward-looking
statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied
in the forward-looking statements. For example, all statements regarding the impact of the incident described above on the Company and
its operations, financial systems, or its financial condition, the scope of the investigation, expectations regarding the adequacy of
insurance, the Company’s plans, objectives, projections and expectations regarding the Company’s operations or financial condition,
and assumptions related thereto are all forward-looking statements. Factors that might cause the Company’s actual results to differ
materially from those anticipated in forward-looking statements include, but are not limited to, the Company’s ongoing assessment
of the impacts of the cybersecurity incident, including the Company’s potential discovery of additional information related to the
incident in connection with its investigation or otherwise; the Company’s expectations regarding its ability to contain and
remediate the cybersecurity incident; the impact of the cybersecurity incident on the Company’s relationships with patients,
employees, and governmental regulators; the legal, reputational, and financial risks resulting from the cybersecurity incident, including
as may arise from any exfiltrated data or any potential regulatory inquiries and/or litigation to which the Company may become subject
in connection with the incident; any further or still undetected cyber security incident; and remediation and other additional
costs that may be incurred by the Company in connection with the investigation and remediation of the incident. The forward-looking statements
speak only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

Item 9.01 - Financial Statements and Exhibits

23 words

Item 9.01.
Financial Statements and Exhibits.

(d)
Exhibits

Exhibit

No.

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).